1 |
A dynamical model of the basal ganglia (Leblois et al 2006) |
2 |
A neural model of Parkinson`s disease (Cutsuridis and Perantonis 2006, Cutsuridis 2006, 2007) |
3 |
A systems model of Parkinson’s disease using biochemical systems theory (Sasidharakurup et al. 2017) |
4 |
Amyloid beta (IA block) effects on a model CA1 pyramidal cell (Morse et al. 2010) |
5 |
Anoxic depolarization, recovery: effect of brain regions and extracellular space (Hubel et al. 2016) |
6 |
Axonal spheroids and conduction defects in Alzheimer’s disease (Yuan, Zhang, Tong, et al 2022) |
7 |
Biologically Constrained Basal Ganglia model (BCBG model) (Lienard, Girard 2014) |
8 |
Breakdown of accmmodation in nerve: a possible role for INAp (Hennings et al 2005) |
9 |
CA3 Network Model of Epileptic Activity (Sanjay et. al, 2015) |
10 |
Cardiac action potential based on Luo-Rudy phase 1 model (Luo and Rudy 1991), (Wu 2004) |
11 |
Cardiac Atrial Cell (Courtemanche et al 1998) (C++) |
12 |
Computational neuropharmacology of CA1 pyramidal neuron (Ferrante et al. 2008) |
13 |
Cortical oscillations and the basal ganglia (Fountas & Shanahan 2017) |
14 |
Criticality,degeneracy in injury-induced changes in primary afferent excitability (Ratte et al 2014) |
15 |
Dentate gyrus network model pattern separation and granule cell scaling in epilepsy (Yim et al 2015) |
16 |
Dorsal root ganglion (DRG) neuronal model (Kovalsky et al. 2009) |
17 |
Dynamic dopamine modulation in the basal ganglia: Learning in Parkinson (Frank et al 2004,2005) |
18 |
Growth Rules for Repair of Asynch Irregular Networks after Peripheral Lesions (Sinha et al 2021) |
19 |
Huntington`s disease model (Gambazzi et al. 2010) |
20 |
Ketamine disrupts theta modulation of gamma in a computer model of hippocampus (Neymotin et al 2011) |
21 |
Markovian model for cardiac sodium channel (Clancy, Rudy 2002) |
22 |
Mechanisms for pattern specificity of DBS in Parkinson's disease (Velarde et al 2017) |
23 |
Method for counting motor units in mice (Major et al 2007) |
24 |
Multiscale model of excitotoxicity in PD (Muddapu and Chakravarthy 2020) |
25 |
Multitarget pharmacology for Dystonia in M1 (Neymotin et al 2016) |
26 |
Neural mass model based on single cell dynamics to model pathophysiology (Zandt et al 2014) |
27 |
Nicotinic control of dopamine release in nucleus accumbens (Maex et al. 2014) |
28 |
Nigral dopaminergic neurons: effects of ethanol on Ih (Migliore et al. 2008) |
29 |
Nodes of Ranvier with left-shifted Nav channels (Boucher et al. 2012) |
30 |
Single-cell comprehensive biophysical model of SN pars compacta (Muddapu & Chakravarthy 2021) |
31 |
Ventromedial Thalamocortical Neuron (Bichler et al 2021) |